Ablation Devices Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2034

Ablation devices are the medical tools that utilizes different types energy in order to destroy targeted tissues and cells. It is used in a procedure to treat atrial fibrillation, by causing small burns or freezes heart cells to cause some scarring on the inside of the heart which helps break up or insulate the electrical signals that cause irregular heartbeats.      

MARKET OVERVIEW 

The market valuation of the ablation devices market was valued at approximately USD xx billion in 2023 and is projected to reach USD xx billion in 2034 exhibiting a CAGR of xx.x% during the forecast period of 2024-2034. The market is aligned with healthcare sector, which makes it a sustainable and growing market.

GROWTH DRIVERS 

The rise in the prevalence of chronic diseases such as cancer and cardiovascular diseases and rise in aging population is one of the key drivers of the market where ablation devices is used for arrhythmia management. As per national Institutes of Health, of the population 50 years and older, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050.

Moreover, at the same those with multimorbidity are projected to increase 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. The growth in the patients demand for minimally invasive procedures including ablation drives the market demand where this shift is drive by reduced recovery time.       
 
MARKET SEGMENTATION: 

·         By Technology- radiofrequency, laser/light ablation, ultrasound ablation, electrical ablation, cryoablation, microwave ablation, pulse-field ablation, hydrothermal/hydromechanical ablation 

·         By Product- systems and services 

·         By Application- cardiovascular, cancer, orthopedic, cosmetic/aesthetic, urological, gynecological, pain management and others 

·         By End Users- hospitals, surgical centers, ablation centers and others 

·         By Regions- North America, Europe, Asia Pacific, South America, Middle East and Africa

Ablation Devices Market Segment by Technology Review: 

The ablation devices utilize different types of technology in order to address specific medical needs and offer certain benefits. For instance, it utilizes radiofrequency technology where it utilizes high frequency alternating current for heat generation in order to destroy abnormal tissues, commonly used in ablation of tumor or pain management.   

            

Regional Analysis: 

North America is a significant market driven by the presence of advanced healthcare infrastructure coupled with robust and strong investment landscape. Europe is another significant market driven by the robust healthcare sector and aging population. APAC is a rapidly growing market driven by rise in healthcare expenditure coupled with high disease burden. MEA is a promising market driven by the rise in healthcare demand and investments in healthcare sector. South America another growing market driven by rise in rise disease burden.

 

Key Challenges: 

The ablation devices involve substantial investment coupled with the maintenance and servicing cost which may deter the market penetration, hindering the market growth. Moreover, handling and operating of these devices requires skilled healthcare professionals, lack of skilled professional or any shortage may hinder the effective adoption.

Competitive Landscape: 

In the highly competitive ablation devices market, companies are investing heavily in research and development to innovate and improve their products and services. They are also collaborating, forming strategic partnerships, or acquiring other companies to gain access to new market segments, enhance distribution networks, and increase market share.

The key news and development includes-

·         In May 2023, Abbott received US Food and Drug Administration (FDA) approval for its TactiFlex Ablation Catheter (Sensor Enabled), which became the world's first ablation catheter featuring a flexible tip and contact force technology.

·         In February 2023, the NovaSure V5 global endometrial ablation (GEA) device of Hologic Inc. was approved for medical usage in Canada and Europe. This innovative version incorporates enhanced features for the treatment of a broad range of cervical and uterine anatomies.

·         In November 2021, Medtronic India launched the Arctic Front Cardiac Cryoablation Catheter System for atrial fibrillation (AF) treatment in the country. The system is used to perform minimally invasive cryoballoon catheter ablation, one of the therapeutic modalities used to manage AF.

·         In January 2021, Medtronic plc received FDA approval for the DiamondTemp Ablation (DTA) system, which is indicated for treating patients with recurrent, symptomatic paroxysmal AF, particularly for those who have been unresponsive to conventional drugs. The DTA is the first FDA-approved, temperature-controlled, irrigated radiofrequency (RF) ablation system with diamonds, which is currently available to deliver ablations.

·         In October 2022, PENTAX Medical, a healthcare company specializing in diagnostic and therapeutic endoscopy solutions, launched the C2 CryoBalloon Ablation System in Canada for treating Barrett's Esophagus.

·         In March 2022, Quantum Surgical received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Epione robot. The Epione robot is designed to plan, target, deliver, and confirm tumor ablation for cancer treatment.

·         In January 2024, J & J received CE mark approval for VARIPULSE Pulse Field Ablation Platform. In December 2023, Medtronic launched Pulse Selected Pulsed Field Ablation System.    

Global Key Players:  

·         Johnson & Johnson

·         Medtronic

·         Boston Scientific Corporation

·         Abbott

·         Atricure, Inc.

·         Olympus Corporation

·         Varian

·         Ethicon

·         CONMED Corporation

·         Elekta AB

·         Other Players

Attributes	Details
Base Year	2023
Trend Period	2024 – 2034
Forecast Period	2024 – 2034
Pages	215
By Technology	radiofrequency, laser/light ablation, ultrasound ablation, electrical ablation, cryoablation, microwave ablation, pulse-field ablation, hydrothermal/hydromechanical ablation
By Product	systems and services
By Application	cardiovascular, cancer, orthopedic, cosmetic/aesthetic, urological, gynecological, pain management and others
By End Users	hospitals, surgical centers, ablation centers and others
By region	North America, Europe, Asia Pacific, the Middle East and Africa, and South America
Company Profiles	Johnson & Johnson, Medtronic, Boston Scientific Corporation, Abbott, Atricure, Inc., Olympus Corporation, Varian, Ethicon, CONMED Corporation, Elekta AB, Other Players
Edition	1st edition
Publication	January 2025